Alexander D. Boiko - Concepedia

Concepedia

Author

Alexander D. Boiko

University of California, Irvine ORCID

Also Known As

A D Boiko, Alexander D. Boiko, Alexander D. Boiko (7444382)

19

Publications

1.5K

Citations

12

H-Index

34

Concepts

All Affiliations

University of California, Irvine Stanford University University of Illinois Chicago Cleveland Clinic Helmholtz Zentrum München

AD

About

Alexander D. Boiko is an author at University of California, Irvine specializing in cell biology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1K
2	Cell Biology	6	6	1K
3	Immunology	3	3	757
4	Natural Sciences	1	1	11
5	Pathology	1	1	34

Alexander D. Boiko

×

13

Publications

1.5K

Citations

12

H-Index

	Year	Citations
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 Alexander D. Boiko, Olga V. Razorenova, Matt van de Rijn, Nature Developmental BiologySkin CancerMelanomaImmunologyNeural Stem Cell	2010	712
Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence Xianghong Zou, Dipankar Ray, Aileen Aziyu, Genes & Development	2002	144
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation Alexander D. Boiko, Sarah Porteous, Olga V. Razorenova, Genes & Development Active P53Tumor BiologyFunctional P53Systems BiologyCell Regulation	2006	138
Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells Tao Lu, Lyudmila G. Burdelya, Shannon M. Swiatkowski, Proceedings of the National Academy of Sciences	2004	103
<i>VHL</i> loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration Olga V. Razorenova, Elizabeth Finger, Renata Colavitti, Proceedings of the National Academy of Sciences Common Genetic MutationCell DeathCancer BiologyTumor BiologySignaling Pathway	2011	84
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts Michael H. Ngo, Arum Han, Anita Lakatos, Cell Reports	2016	72
Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling Chen Li, Vincent Nguyen, Kaitlyn N. Clark, Proceedings of the National Academy of Sciences	2019	61
Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms Arum Han, Chen Li, Tara Zahed, PLoS Biology Mptp InhibitorApoptosisImmunologyPathologyCell Death	2019	34
Therapeutic implications of melanoma heterogeneity Stephanie J. Hachey, Alexander D. Boiko Experimental Dermatology Melanoma HeterogeneityTumor DiversityTumor HeterogeneityMedicinePhotocarcinogenesis	2016	33
CD271 is a molecular switch with divergent roles in melanoma and melanocyte development Fabian V. Filipp, Chen Li, Alexander D. Boiko Scientific Reports	2019	28

Page 1